P350 Serum CRP is a better early marker for response to infliximab induction therapy than fecal calprotectin in patients with moderate to severe ulcerative colitis

Authors
Publication date
1 February 2014
Publisher
Oxford University Press (OUP)
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fs1873-9946%...
      Last time updated on 01/05/2021